Contact Us
Reader Logo
Contact Us

Tag: Regulatory

Regulatory

Tags

AbC-19 Rapid Antibody Test Science Behind Lateral Flow LFIA Development Case Study NALFIA LFIA Education Pharma LFIA Manufacturing Point Of Care MHealth Announcements Appointments Charity Investor Launch Publications Regulatory Smartphone Readers
  • Product News
November 17, 2020

Abingdon Health completes FDA Section IV.D notification process

COVID-19 neutralising antibody test, AbC-19, available to CLIA testing labs in the USA following the completion of FDA Section IV.D by Abingdon Health

Read Now
March 3, 2020

Be IVDR ready to protect your assay and business

Learn about the key changes to the In Vitro Diagnostic Directive and the areas you should be actively considering.

Read Now
February 3, 2020

Grasp ‘Software as a Medical Device’ regulation for success in the US mHealth market

mHealth Software Regulation: part II: Regulations for mHealth in the USA, the largest diagnostic market.

Read Now
January 27, 2020

MHealth software is big business: understand regulations and be a leader in this area

mHealth Software Regulation: part I: European regulation surrounding the rapid growing mHealth market.

Read Now
November 12, 2019

Octylphenol ethoxylates (OPE) usage deadline looming

Octylphenol ethoxylates are now included in the Annex XIV of REACH. What does it mean for LFIAs that use OPEs?

Read Now
  • Company News
  • Product News
June 5, 2017

Extensive Clinical Validation Study for Seralite®-FLC

A peer-reviewed scientific publication featuring detailed clinical validation of Seralite®-FLC has been published in the British Journal of Haematology and is now available...

Read Now
  • Company News
  • Product News
July 22, 2016

FDA registration and CE marking of new lateral flow immunoassay Reader, ADxLR5®

Abingdon Health announces FDA registration and CE marking of new lateral flow immunoassay Reader – ADxLR5® Abingdon Health is pleased to announce the...

Read Now